Skip to main content
. 2011 Jun 21;16(6):265–274. doi: 10.1186/2047-783X-16-6-265

Figure 3.

Figure 3

Gastric adenocarcinomas after neoadjuvant chemotherapy showing no tumor regression (A) or major regression with only few scattered vital residual tumor cells (B). Adenocarcinoma of the gastro-esophageal junction exhibiting major regression after radio-chemotherapy (C, D).